CoChat

Obesity treatment by epigallocatechin‐3‐gallate−regulated bile acid signaling and its enriched Akkermansia muciniphila

Open access
Sheng, Lili, Jena, Prasant Kumar, Liu, Hui‐Xin, Hu, Ying, Nagar, Nidhi, Bronner, Denise N., Settles, Matthew L., Baümler, Andreas J., Wan, Yu‐Jui Yvonne · 2018 · The FASEB Journal
Cited by 128

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Dysregulated bile acid (BA) synthesis is accompanied by dysbiosis, leading to compromised metabolism. This study analyzes the effect of epigallocatechin‐3‐gallate (EGCG) on diet‐induced obesity through regulation of BA signaling and gut microbiota. The data revealed that EGCG effectively reduced diet‐increased obesity, visceral fat, and insulin resistance. Gene profiling data showed that EGCG had a significant impact on regulating genes implicated in fatty acid uptake, adipogenesis, and metabolism in the adipose tissue. In addition, metabolomics analysis revealed that EGCG altered the lipid and sugar metabolic pathways. In the intestine, EGCG reduced the FXR agonist chenodeoxycholic acid, as well as the FXR‐regulated pathway, suggesting intestinal FXR deactivation. However, in the liver, EGCG increased the concentration of FXR and TGR‐5 agonists and their regulated signaling. Furthermore, our data suggested that EGCG activated Takeda G protein receptor (TGR)‐5 based on increased GLP‐1 release and elevated serum PYY level. EGCG and antibiotics had distinct antibacterial effects. They also differentially altered body weight and BA composition. EGCG, but not antibiotics, increased Verrucomicrobiaceae, under which EGCG promoted intestinal bloom of Akkermansia muciniphila . Excitingly, A. muciniphila was as effective as EGCG in treating diet‐induced obesity. Together, EGCG shifts gut microbiota and regulates BA signaling thereby having a metabolic beneficial effect.—Sheng, L., Jena, P. K., Liu, H.‐X., Hu, Y., Nagar, N., Bronner, D. N., Settles, M. L., Baumler, A. J., Wan, Y.‐J. Y. Obesity treatment by epigallocatechin‐3‐gallate−regulated bile acid signaling and its enriched Akkermansia muciniphila . FASEB J. 32, 6371–6384 (2018). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.201800370r

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 128

Metadata

Authors
Sheng, L., Jena, P. K., Liu, H., Hu, Y., Nagar, N., Bronner, D. N., Settles, M. L., Baümler, A. J., & Wan, Y. Y.
Venue
The FASEB Journal
Publisher
Wiley
Published
2018-06-08
Volume
32
Issue
12
Pages
6371-6384
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2807353008
Cited by
128
References
17
FWCI
5.18
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Obesity treatment by epigallocatechin‐3‐gallate−regulated bile acid signaling and its enriched Akkermansia muciniphila. https://app.cochat.ai/papers/10.1096/fj.201800370r
The paper
Sheng, L., Jena, P. K., Liu, H., Hu, Y., Nagar, N., Bronner, D. N., Settles, M. L., Baümler, A. J., & Wan, Y. Y. (2018). Obesity treatment by epigallocatechin‐3‐gallate−regulated bile acid signaling and its enriched Akkermansia muciniphila. The FASEB Journal. https://doi.org/10.1096/fj.201800370r

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.